Lck-IN-3 (compound 7m) is an LCK inhibitor that targets acute lymphoblastic leukemia (ALL) by inhibiting LCK phosphorylation. Lck-IN-3 can induce cell cycle arrest at the G2/M phase, leading to apoptosis in ALL cells.
Formula:
C28H22N6O2S
Target:
Apoptosis|||Src
* VAT and and shipping costs not included. Errors and price changes excepted
